SELLAS Life Sciences Group Inc
SLS
|
|
| |
|
| Trading Volume | 20,035 |
|
|
1.82 - 0.51 |
| Market Cap Full | $ 41.7M |
Quarterly +
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Q1 | 1.9% | -5.7% | -39.4% | 20.8% |
| Q2 | - | 4.6% | 9.8% | -66.6% |
| Q3 | - | 13% | 4.5% | -9.4% |
| Q4 | - | -16.8% | -32.5% | 16.8% |
Monthly +
| J | F | M | A | M | J | J | A | S | O | N | D |
| 2025 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.9 | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | |||||||||||
| -39.6 | 57.8 | -1 | 52 | -7.2 | -19.2 | 0.9 | 13 | - | - | - | -9.6 |
| 2023 | |||||||||||
| 40.7 | -49.1 | -15.4 | -1.8 | 22.1 | -8.5 | 4.5 | -10.4 | 11.6 | -40.9 | 7.2 | 1.9 |
| 2022 | |||||||||||
| -3.4 | 14.2 | 9.5 | -59.3 | 12.1 | -26.9 | 12.6 | 19.9 | -32.9 | 131.7 | -48.9 | -1.3 |
| 2021 | |||||||||||
| 6.5 | 33.3 | 5 | -7.7 | 51.8 | -7.2 | -22 | 7.3 | -1.4 | -4.8 | -22.7 | -18 |
| 2020 | |||||||||||
| -32.9 | -27.7 | -14.6 | 46.2 | 35.6 | -14.6 | 21.5 | -40.7 | 18.5 | 2.4 | 42 | 57.6 |
EPS
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
| Q1 | -0.5 | -1.1 | -0.2 | -0.7 |
| Q2 | -0.3 | -0.4 | -0.3 | -0.7 |
| Q3 | -0.3 | -0.3 | -0.5 | -0.5 |
| Q4 | 0 | -0.3 | -0.4 | -0.3 |
| A | -1.11 | -2.1 | -1.3 | -2.1 |